Rallybio CorporationRLYBNASDAQ

Revenue (LTM)

$858000

+34.9% YoY

Net Income (LTM)

$-9M

+84.5% YoY

Free Cash Flow

$-30M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	1	1↑34.9%
Gross Profit	-0	-0↓53.2%	-0↑10.2%	1↑524.0%	1↑20.4%
Operating Income	-46	-68↓48.7%	-79↓16.3%	-60↑23.4%	-28↑53.6%
Net Income	-47	-67↓41.8%	-75↓11.9%	-58↑22.5%	-9↑84.5%
EBITDA	-45	-68↓49.2%	-79↓16.3%	-60↑23.4%	-28↑53.7%
EPS Diluted	-11.68	-16.72↓43.2%	-14.72↑12.0%	-10.64↑27.7%	-1.59↑85.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	175	57↓67.5%	24↓57.0%	14↓43.2%	31↑125.7%
Total Current Assets	181	179↓0.8%	115↓36.0%	68↓40.9%	61↓9.7%
Total Assets	182	180↓1.0%	116↓35.9%	68↓41.1%	62↓8.6%
Total Current Liabilities	7	11↑64.0%	9↓13.8%	6↓32.6%	4↓32.3%
Total Liabilities	7	11↑68.9%	9↓15.1%	6↓31.6%	4↓33.3%
Total Equity	176	169↓3.6%	106↓37.3%	62↓41.9%	58↓6.0%
Total Debt	0	1	0↓29.4%	0↓60.7%	0↑14.3%
Net Debt	-175	-56↑67.8%	-24↑57.3%	-14↑43.0%	-31↓126.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-46	-57↓25.8%	-60↓5.2%	-49↑18.2%	-30↑39.5%
Capital Expenditure	-0	-0↑83.8%	-0↑77.8%	0	0
Free Cash Flow	-46	-57↓25.0%	-60↓5.1%	-49↑18.2%	-30↑39.5%
Stock-Based Comp	4	9↑160.6%	11↑15.0%	8↓26.8%	5↓33.5%
Net Change in Cash	35	-118↓437.2%	-32↑72.6%	-11↑67.4%	17↑265.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance